Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

Nicola A Hanania1 Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USACorrespondence[email protected]
View further author information

Jorge F Maspero2 Fundación CIDEA, Buenos Aires, ArgentinaView further author information

David M G Halpin3 University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK

https://orcid.org/0000-0003-2009-4406 View further author information

David J Jackson4 School of Immunology and Microbial Sciences, King’s College London, London, UK;5 Guy’s Severe Asthma Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, UKView further author information

Reynold A Panettieri6 Child Health Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA

https://orcid.org/0000-0003-0834-4636 View further author information

Mario Castro7 University of Kansas School of Medicine, Kansas City, KS, USAView further author information

Christian Domingo8 Pulmonary Service, Corporació Sanitària Parc Taulí, Sabadell, Autonomous University of Barcelona, Barcelona, SpainView further author information

Nadia Daizadeh9 Sanofi, Cambridge, MA, USAView further author information

Rebecca Gall10 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information

Juby A Jacob-Nara11 Sanofi, Bridgewater, NJ, USAView further author information

Benjamin Ortiz10 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information

Michel Djandji9 Sanofi, Cambridge, MA, USAView further author information

Paul J Rowe11 Sanofi, Bridgewater, NJ, USAView further author information

Yamo Deniz10 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information

show all

References

Tepper RS, Wise RS, Covar R, et al. Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol. 2012;129(3 Suppl):S65–S87. doi:10.1016/j.jaci.2011.12.986
PubMed Web of Science ®Google Scholar
Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2021. Available from: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf. Accessed December 10, 2021.
Google Scholar
Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J. 1999;14(1):23–27. doi:10.1034/j.1399-3003.1999.14a06.x
PubMed Web of Science ®Google Scholar
Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486–2496. doi:10.1056/NEJMoa1804092
PubMed Web of Science ®Google Scholar
Castro M, Rabe KF, Corren J, et al. Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma. ERJ Open Res. 2020;6(1):00204–2019. doi:10.1183/23120541.00204-2019
PubMedGoogle Scholar
Papi A, Castro M, Corren J, et al. Long-term effect of dupilumab on lung function in patients with type 2 asthma: LIBERTY ASTHMA TRAVERSE study. Presented at the 2021 CHEST Annual Meeting; October 17-20; 2021; Orlando, FL, USA.
Google Scholar

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date